ANI Pharmaceuticals (ANIP) Short Interest Ratio & Short Volume → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free ANIP Stock Alerts $65.50 +0.55 (+0.85%) (As of 03:01 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability ANI Pharmaceuticals Short Interest DataCurrent Short Volume213,500 sharesPrevious Short Volume197,000 sharesChange Vs. Previous Month+8.38%Dollar Volume Sold Short$14.16 millionShort Interest Ratio / Days to Cover1.5Last Record DateApril 15, 2024Outstanding Shares21,080,000 sharesPercentage of Shares Shorted1.01%Today's Trading Volume32,430 sharesAverage Trading Volume135,691 sharesToday's Volume Vs. Average24% Short Selling ANI Pharmaceuticals ? Sign up to receive the latest short interest report for ANI Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatANIP Short Interest Over TimeANIP Days to Cover Over TimeANIP Percentage of Float Shorted Over Time Ad Stansberry ResearchMove Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. ANI Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024213,500 shares $14.16 million +8.4%N/A1.5 $66.30 3/31/2024197,000 shares $13.62 million -24.7%N/A1.4 $69.13 3/15/2024261,600 shares $17.27 million +5.0%N/A1.9 $66.00 2/29/2024249,100 shares $16.86 million +16.7%N/A1.8 $67.67 2/15/2024213,400 shares $12.28 million -11.9%N/A1.7 $57.55 1/31/2024242,200 shares $13.52 million +8.2%N/A1.6 $55.82 Get the Latest News and Ratings for ANIP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ANI Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024223,900 shares $12.70 million -15.2%N/A1.4 $56.74 12/31/2023264,000 shares $14.56 million -34.0%N/A1.5 $55.14 12/15/2023399,700 shares $21.15 million -0.5%N/A2.3 $52.91 11/30/2023401,700 shares $20.01 million +6.6%N/A2.4 $49.81 11/15/2023376,800 shares $19.71 million -11.0%N/A2.2 $52.30 10/31/2023423,400 shares $26.14 million +1.9%N/A2.2 $61.74 10/15/2023415,400 shares $23.95 million -6.4%N/A2.5 $57.66 9/30/2023444,000 shares $25.78 million +44.9%N/A2.8 $58.06 9/15/2023306,500 shares $19.12 million +15.8%N/A2 $62.39 8/31/2023264,800 shares $17.05 million -7.5%N/A1.7 $64.39 8/15/2023286,200 shares $17.71 million -15.7%N/A2 $61.89 7/31/2023339,300 shares $17.83 million -2.0%N/A2.3 $52.55 7/15/2023346,200 shares $17.41 million +3.8%N/A2.5 $50.28 6/30/2023333,700 shares $17.96 million +21.8%N/A2.5 $53.83 6/15/2023274,000 shares $13.89 million +7.2%N/A2.2 $50.71 5/31/2023255,600 shares $11.54 million -24.1%N/A2.3 $45.14 5/15/2023336,900 shares $13.77 million -15.9%N/A3.2 $40.88 4/30/2023400,700 shares $15.11 million +14.7%N/A5.8 $37.72 4/15/2023349,500 shares $13.43 million +4.7%N/A5.5 $38.42 3/31/2023333,800 shares $13.26 million -3.9%2.6%5.1 $39.72 3/15/2023347,200 shares $13.89 million +15.3%N/A5.1 $40.01 2/28/2023301,100 shares $12.60 million -4.6%N/A4.5 $41.84 2/15/2023315,500 shares $14.21 million -4.3%N/A4.7 $45.04 1/31/2023329,600 shares $14.74 million +1.2%N/A4.5 $44.73 1/15/2023325,700 shares $14.31 million -4.9%N/A4.6 $43.95 12/30/2022342,300 shares $13.77 million -20.0%N/A5 $40.23 12/15/2022427,700 shares $16.78 million -4.3%N/A6.5 $39.24 11/30/2022447,000 shares $18.75 million -11.0%N/A6.7 $41.95 11/15/2022502,200 shares $18.38 million -12.5%4.0%7.5 $36.60 10/31/2022573,700 shares $22.14 million +1.0%4.6%8.8 $38.59 10/15/2022568,000 shares $18.87 million -15.3%4.5%8.4 $33.22 9/30/2022670,700 shares $21.56 million -2.7%5.4%9.1 $32.14 9/15/2022689,200 shares $25.10 million -1.0%5.5%8 $36.42 8/31/2022696,200 shares $25.68 million +4.4%5.6%7.6 $36.89Move Your Money Before May 1 (Ad)Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. ANIP Short Interest - Frequently Asked Questions What is ANI Pharmaceuticals' current short interest? Short interest is the volume of ANI Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 213,500 shares of ANIP short. Learn More on ANI Pharmaceuticals' current short interest. What is a good short interest ratio for ANI Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANIP shares currently have a short interest ratio of 2.0. Learn More on ANI Pharmaceuticals's short interest ratio. Which institutional investors are shorting ANI Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ANI Pharmaceuticals: Simplex Trading LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is ANI Pharmaceuticals' short interest increasing or decreasing? ANI Pharmaceuticals saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 213,500 shares, an increase of 8.4% from the previous total of 197,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ANI Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to ANI Pharmaceuticals: Arcus Biosciences, Inc. (14.45%), Kura Oncology, Inc. (15.93%), Gyre Therapeutics, Inc. (1.30%), Morphic Holding, Inc. (12.49%), Akero Therapeutics, Inc. (11.83%), Day One Biopharmaceuticals, Inc. (15.17%), Edgewise Therapeutics, Inc. (9.15%), Ardelyx, Inc. (14.58%), Ironwood Pharmaceuticals, Inc. (13.96%), Zai Lab Limited (4.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short ANI Pharmaceuticals stock? Short selling ANIP is an investing strategy that aims to generate trading profit from ANI Pharmaceuticals as its price is falling. ANIP shares are trading up $0.52 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ANI Pharmaceuticals? A short squeeze for ANI Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ANIP, which in turn drives the price of the stock up even further. How often is ANI Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANIP, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Arcus Biosciences Short Interest Kura Oncology Short Interest Gyre Therapeutics Short Interest Morphic Short Interest Akero Therapeutics Short Interest Day One Biopharmaceuticals Short Interest Edgewise Therapeutics Short Interest Ardelyx Short Interest Ironwood Pharmaceuticals Short Interest Zai Lab Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ANIP) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJim Cramer’s “The Biggest Drug Ever”Behind the Markets